AlphaYouGC
Insider selling
Gillian Cannon sold $63K of Xenon Pharmaceuticals Inc. (XENE) stock
Gillian Cannon, Dir of Xenon Pharmaceuticals Inc. (XENE), sold 1,190 shares of XENE stock worth $63K, per an SEC Form 4 filed Jun 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 5, 2026, 3 days before it was made public.
XENE has moved -24.6% since the trade date, from $51.73 to $38.99 (Sep 21, 2026 close).
- Traded
- Jun 5, 2026
- Disclosed
- Jun 8, 2026
- Filing delay
- 3 days
- Price since
- -24.6%
- Role
- Dir
- Source
- SEC Form 4
More XENE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.